Halozyme Therapeutics | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
Amarin USD 58.77M 56.06M 2025-03
Amgen USD 6.52B 337M 2025-06
Baxter International USD 2.54B 29M 2025-06
Cytokinetics USD 178.28M 21.06M 2025-06
DBV Technologies USD 27.37M 3M 2025-03
Eli Lilly USD 8.54B 1.22B 2025-06
Halozyme Therapeutics USD 123.28M 48K 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
MannKind USD 65.86M 9.8M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06


Halozyme Therapeutics Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.